Cargando…
Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies
Cannabinoid co-administration may enable reduced opioid doses for analgesia. This updated systematic review on the opioid-sparing effects of cannabinoids considered preclinical and clinical studies where the outcome was analgesia or opioid dose requirements. We searched Scopus, Cochrane Central Regi...
Autores principales: | Nielsen, Suzanne, Picco, Louisa, Murnion, Bridin, Winters, Bryony, Matheson, Justin, Graham, Myfanwy, Campbell, Gabrielle, Parvaresh, Laila, Khor, Kok-Eng, Betz-Stablein, Brigid, Farrell, Michael, Lintzeris, Nicholas, Le Foll, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117273/ https://www.ncbi.nlm.nih.gov/pubmed/35459926 http://dx.doi.org/10.1038/s41386-022-01322-4 |
Ejemplares similares
-
Current Insights on the Impact of Gamma-Hydroxybutyrate (GHB) Abuse
por: Tay, Emma, et al.
Publicado: (2022) -
Overdiagnosis in Melanoma Screening: Is It a Real Problem?
por: Betz-Stablein, Brigid, et al.
Publicado: (2023) -
Experiences of misuse and symptoms of dependence among people who use gabapentinoids: a qualitative systematic review protocol
por: McNeilage, Amy Gray, et al.
Publicado: (2023) -
‘It’s a fragile open door’—enhancing COVID-19 vaccination rates in people receiving treatment for substance use disorder
por: Murnion, Bridin, et al.
Publicado: (2023) -
Do gabapentin or pregabalin directly modulate the µ receptor?
por: Manandhar, Preeti, et al.
Publicado: (2021)